Need for an addendum on the clinical investigation of medicinal products intended for treatment of glucocorticoid-induced osteoporosis

Current version

PDF iconConcept paper

Reference numberCHMP/EWP/15912/10
Published29/01/2010
KeywordsOsteoporosis, glucocorticoids, secondary osteoporosis, postmenopausal osteoporosis, endpoints
DescriptionThis document reflects the need for an addendum on glucocorticoid-induced osteoporosis to the guideline on the clinical investigation of medicinal products used in the treatment of osteoarthritis.

How useful was this page?

Add your rating